Post-approval studies (Phase 4)Study completedNCT01863433
What this trial is testing
Assess the Immunogenicity and Safety of a Trivalent Influenza Vaccine Containing the 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers
Who this might be right for
Influenza, Human
Seqirus 120